8-K: American Healthcare REIT Boosts 2024 Guidance After Strong Q3 Performance and Trilogy Acquisition
Quarterly Report
American Healthcare REIT announced increased full-year 2024 guidance, driven by strong third-quarter results and the acquisition of the remaining stake in Trilogy.
Summary
- American Healthcare REIT reported a GAAP net loss of $(3.1) million, or $(0.03) per diluted share, for the third quarter of 2024.
- The company's Normalized Funds from Operations (NFFO) was $0.36 per diluted share for the same period.
- Same-Store Net Operating Income (NOI) grew by 17.0% for the total portfolio, with significant growth in senior housing operating properties (SHOP) at 61.8% and integrated senior health campuses (ISHC) at 22.6%.
- The company increased its full-year 2024 Same-Store NOI growth guidance to a range of 15.0% to 17.0%, up from the previous 12.0% to 14.0%.
- American Healthcare REIT completed a follow-on equity offering of approximately 20.0 million shares, raising gross proceeds of approximately $471.2 million.
- The company acquired the remaining 24% minority interest in Trilogy for approximately $258.0 million in cash, making it the sole owner.
- Full-year 2024 NFFO guidance was increased to a range of $1.40 to $1.43 per share, up from the previous $1.23 to $1.27.
- The company's Net-Debt-to-Annualized Adjusted EBITDA improved to 5.1x as of September 30, 2024, from 5.9x as of June 30, 2024.
Sentiment
Score: 9
Explanation: The document conveys a very positive sentiment due to the strong financial performance, strategic acquisitions, and increased guidance. The company's operational improvements and successful capital raising activities are also viewed favorably.
Positives
- The company experienced strong Same-Store NOI growth across its portfolio, particularly in the SHOP and ISHC segments.
- The successful equity offering provided significant capital for acquisitions and debt reduction.
- Becoming the sole owner of Trilogy is expected to enhance the company's ISHC segment.
- The company's leverage profile improved with a reduction in Net-Debt-to-Annualized Adjusted EBITDA.
- The increased full-year guidance reflects management's positive outlook on portfolio performance and recent transactions.
Negatives
- The company reported a GAAP net loss of $(3.1) million for the third quarter of 2024.
- The Outpatient Medical segment experienced minimal Same-Store NOI growth at 0.1% for the quarter.
Risks
- The company's forward-looking statements are subject to various risks and uncertainties that could cause actual results to differ materially.
- The company is unable to provide guidance for the most comparable GAAP financial measures of total revenues and property operating and maintenance expenses.
- The company is unable to reasonably predict certain items contained in the GAAP measures, including non-recurring and infrequent items that are not indicative of the company's ongoing operations.
Future Outlook
The company expects to continue to expand its ISHC segment as the sole owner of Trilogy and pursue external growth within its SHOP segment. The company has increased its full-year 2024 guidance for both Same-Store NOI growth and NFFO per share.
Management Comments
- We are excited to have completed our follow-on offering and the acquisition of the remaining minority membership interest in Trilogy Holdings, said Danny Prosky, the Company's President and Chief Executive Officer.
- As the sole owner of Trilogy, we expect to continue to expand our ISHC segment while providing high-quality healthcare to the communities Trilogy's campuses serve.
- Beyond Trilogy, we aim to pursue external growth within our SHOP segment alongside our existing regional operators, which is where we currently see the best risk-adjusted returns in healthcare real estate.
- As a result of the accretive purchase of the part of Trilogy Holdings that we did not own, utilizing net proceeds from our recent equity offering as well as the continued improvements in our property performance, we are increasing our full year 2024 NFFO and Same-Store NOI guidance, said Brian Peay, the Company's Chief Financial Officer.
- That same offering provided us with excess proceeds which went to pay down debt in the quarter, and that, along with the improved property performance, allowed us to improve our overall liquidity and decrease our company's leverage profile.
Industry Context
This announcement reflects a positive trend in the healthcare REIT sector, with a focus on senior housing and integrated health campuses. The company's strategic acquisitions and operational improvements align with the industry's emphasis on growth and efficiency. The increased guidance suggests a strong market demand for healthcare real estate and the company's ability to capitalize on these opportunities.
Comparison to Industry Standards
- The 17.0% Same-Store NOI growth for the total portfolio is significantly higher than the average for healthcare REITs, which typically see growth in the low to mid-single digits.
- The 61.8% Same-Store NOI growth in the SHOP segment is exceptional, indicating strong operational performance and demand in this sector, compared to peers such as Welltower (WELL) and Ventas (VTR) which have reported more modest growth in their senior housing portfolios.
- The acquisition of the remaining stake in Trilogy is a strategic move to consolidate operations and enhance the ISHC segment, similar to moves by other REITs to vertically integrate their operations.
- The improvement in Net-Debt-to-Annualized Adjusted EBITDA to 5.1x is a positive sign of financial health, placing the company in a better position than some of its more leveraged peers.
- The revised NFFO guidance of $1.40 to $1.43 per share is a strong indicator of future profitability, and is higher than many of its peers in the healthcare REIT space.
Stakeholder Impact
- Shareholders will benefit from the increased guidance and improved financial performance.
- Employees may experience increased job security and opportunities due to the company's growth.
- Customers (residents and patients) will benefit from the company's focus on providing high-quality healthcare services.
- Creditors will benefit from the company's improved leverage profile and debt reduction.
Next Steps
- The company will host a webcast and conference call on November 13, 2024, to discuss the third quarter results.
- The company will continue to focus on expanding its ISHC segment and pursuing external growth within its SHOP segment.
- The company will continue to manage its debt and leverage profile.
Key Dates
| Date | Description |
|---|---|
| September 3, 2024 | The company acquired a senior housing portfolio in Washington. |
| September 20, 2024 | The company completed a follow-on equity offering and acquired the remaining minority interest in Trilogy. |
| September 30, 2024 | The end of the third quarter, for which financial results were reported. |
| October 1, 2024 | The company acquired a SHOP asset in the Atlanta MSA. |
| October 16, 2024 | The company sold one Outpatient Medical building. |
| October 18, 2024 | The third quarter distribution was paid in cash to stockholders. |
| November 12, 2024 | Date of the earnings release and supplemental data. |
| November 13, 2024 | The company will host a webcast and conference call to discuss the results. |
Keywords
Healthcare REIT, Senior Housing, Real Estate Investment Trust, NFFO, Same-Store NOI, Trilogy, Equity Offering, ISHC, SHOP, Net Debt, EBITDA
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.